News
LGT Capital Partners leads continuation vehicle of approximately USD 300 million for Accredited Labs
LGT Capital Partners today announced its role as lead investor in a single-asset continuation vehicle of approximately USD 300 million for Accredited Labs, a portfolio company of Incline Equity Partners. The transaction marks a milestone in the partnership between LGT Capital Partners and Incline, underscoring a shared commitment to long-term value creation in the mid-market.
Accredited Labs, headquartered in Dallas, Texas, is a national provider of calibration and repair services for mission-critical test and measurement equipment. Since Incline’s initial investment in 2023, the company has completed 24 acquisitions, significantly expanding its service capacity and geographic footprint. The continuation vehicle provides the capital needed to support Accredited Labs through its next phase of growth, including further strategic M&A and service enhancement initiatives.
Caroline Bliss, Principal at LGT Capital Partners, said: “We are pleased to support Incline and Accredited Labs in this next chapter. The company’s rapid expansion and diversification across regulated end markets reflect the strength of the platform and the quality of its leadership. We look forward to partnering with Accredited Labs as it builds on its strong foundation and pursues new opportunities for expansion and innovation.”
David Andryc, Partner at LGT Capital Partners, added: “Our long-standing partnership with Incline reflects our commitment to being a trusted, value-adding partner to leading mid-market sponsors. The transaction underscores our ability to provide bespoke liquidity solutions that align the interests of GPs, investors and management teams while supporting continued growth and innovation.”
Since 2015, LGT Capital Partners has completed more than 100 single-asset liquidity deals across different transaction types, partnering with private equity sponsors to provide tailored capital solutions that enable liquidity and support long-term value creation. The investment in Accredited Labs exemplifies this strategy and reinforces the firm’s position as a global partner for private equity managers and their portfolio companies.
